Ware Brenton R, Liu Jennifer S, Monckton Chase P, Ballinger Kimberly R, Khetani Salman R
School of Biomedical Engineering, Colorado State University, Fort Collins, Colorado 80523, USA.
Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois 60607, USA.
Toxicol Sci. 2021 Apr 27;181(1):90-104. doi: 10.1093/toxsci/kfab018.
Human liver models are useful for assessing compound metabolism/toxicity; however, primary human hepatocyte (PHH) lots are limited and highly variable in quality/viability. In contrast, cell lines, such as HepaRG, are cheaper and more reproducible surrogates for initial compound screening; however, hepatic functions and sensitivity for drug outcomes need improvement. Here, we show that HepaRGs cocultured with murine embryonic 3T3-J2 fibroblasts, previously shown to induce PHH functions, could address such limitations. We either micropatterned HepaRGs or seeded them "randomly" onto collagen-coated plates before 3T3-J2 coculture. Micropatterned cocultures (HepaRG-MPCCs) secreted 2- to 4-fold more albumin and displayed more stable cytochrome P450 activities than HepaRG conventional confluent monocultures (HepaRG-CCs) and HepaRG micropatterned hepatocytes (HepaRG-MPHs) for 4 weeks, even when excluding dimethyl sulfoxide from the medium. Furthermore, HepaRG-MPCCs had the most albumin-only positive cells (hepatic), lowest cytokeratin 19 (CK19)-only positive cells (cholangiocytic), and highest mean albumin intensity per cell than HepaRG random cocultures and monocultures; however, 80%-84% of HepaRGs remained bipotential (albumin+/CK19+) across all models. The 3T3-J2s also induced higher albumin in HepaRG spheroids than HepaRG-only spheroids. Additionally, although rifampin induced CYP3A4 in HepaRG-MPCCs and HepaRG-CCs, only HepaRG-MPCCs showed the dual omeprazole-mediated CYP1A2/3A4 induction as with PHHs. Lastly, when treated for 6 days with 47 drugs and evaluated for albumin and ATP to make binary hepatotoxicity calls, HepaRG-MPCCs displayed a sensitivity of 54% and specificity of 100% (70%/100% in PHH-MPCCs), whereas HepaRG-CCs misclassified several hepatotoxins. Ultimately, HepaRG-MPCCs could be a more cost-effective and reproducible model than PHHs for executing a tier 1 compound screen.
人类肝脏模型对于评估化合物代谢/毒性很有用;然而,原代人肝细胞(PHH)批次有限,且质量/活力差异很大。相比之下,细胞系,如HepaRG,作为初始化合物筛选的替代物更便宜且更具可重复性;然而,其肝功能和对药物结果的敏感性仍需改善。在此,我们表明,与先前已证明可诱导PHH功能的小鼠胚胎3T3-J2成纤维细胞共培养的HepaRG细胞可以克服这些局限性。在与3T3-J2共培养之前,我们要么对HepaRG细胞进行微图案化处理,要么将它们“随机”接种到胶原蛋白包被的培养板上。微图案化共培养物(HepaRG-MPCCs)分泌的白蛋白比HepaRG传统汇合单培养物(HepaRG-CCs)和HepaRG微图案化肝细胞(HepaRG-MPHs)多2至4倍,并且在4周内细胞色素P450活性更稳定,即使培养基中不添加二甲基亚砜也是如此。此外,与HepaRG随机共培养物和单培养物相比,HepaRG-MPCCs中仅白蛋白阳性的细胞(肝细胞)最多,仅细胞角蛋白19(CK19)阳性的细胞(胆管细胞)最少,且每个细胞的平均白蛋白强度最高;然而,在所有模型中,80%-84%的HepaRG细胞仍具有双潜能(白蛋白+/CK19+)。3T3-J2细胞还能诱导HepaRG球体产生比仅HepaRG球体更高水平的白蛋白。此外,虽然利福平可诱导HepaRG-MPCCs和HepaRG-CCs中的CYP3A4,但只有HepaRG-MPCCs表现出与PHH细胞一样的奥美拉唑介导的CYP1A2/3A4双重诱导作用。最后,当用47种药物处理6天并评估白蛋白和ATP以进行二元肝毒性判定时,HepaRG-MPCCs的敏感性为54%,特异性为100%(PHH-MPCCs为70%/100%),而HepaRG-CCs将几种肝毒素误分类。最终,对于执行一级化合物筛选而言,HepaRG-MPCCs可能是一种比PHH细胞更具成本效益且更具可重复性的模型。